Literature DB >> 23009936

Role of germline genetic factors in MPN pathogenesis.

Ashot S Harutyunyan1, Robert Kralovics.   

Abstract

It is thought that myeloproliferative neoplasms (MPNs) are driven by somatic mutations, although hereditary factors also play a prominent role in the pathogenesis of the disease. Hereditary thrombocytosis and erythrocytosis are not malignant disorders but are clinically similar to MPNs. Several mutations have been found that explain a proportion of hereditary thrombocytosis and hereditary erythrocytosis. Germline variants can influence the risk of leukemic transformation in MPNs and the course of the disease through interaction with acquired chromosomal aberrations. Overall, it has been shown that germline factors play an important part in MPN pathogenesis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23009936     DOI: 10.1016/j.hoc.2012.07.005

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  10 in total

1.  Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms.

Authors:  Jelena D Milosevic Feenstra; Harini Nivarthi; Heinz Gisslinger; Emilie Leroy; Elisa Rumi; Ilyas Chachoua; Klaudia Bagienski; Blanka Kubesova; Daniela Pietra; Bettina Gisslinger; Chiara Milanesi; Roland Jäger; Doris Chen; Tiina Berg; Martin Schalling; Michael Schuster; Christoph Bock; Stefan N Constantinescu; Mario Cazzola; Robert Kralovics
Journal:  Blood       Date:  2015-09-30       Impact factor: 22.113

2.  CHST15 gene germline mutation is associated with the development of familial myeloproliferative neoplasms and higher transformation risk.

Authors:  Yi Chen; Yang Zhang; Zhihua Wang; Yewei Wang; Yujiao Luo; Nannan Sun; Shasha Zheng; Wenzhe Yan; Xiang Xiao; Sufang Liu; Ji Li; Hongling Peng; Yunxiao Xu; Guoyu Hu; Zhao Cheng; Guangsen Zhang
Journal:  Cell Death Dis       Date:  2022-07-07       Impact factor: 9.685

3.  Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.

Authors:  Joseph Saliba; Cécile Saint-Martin; Antonio Di Stefano; Gaëlle Lenglet; Caroline Marty; Boris Keren; Florence Pasquier; Véronique Della Valle; Lise Secardin; Gwendoline Leroy; Emna Mahfoudhi; Sarah Grosjean; Nathalie Droin; M'boyba Diop; Philippe Dessen; Sabine Charrier; Alberta Palazzo; Jane Merlevede; Jean-Côme Meniane; Christine Delaunay-Darivon; Pascal Fuseau; Françoise Isnard; Nicole Casadevall; Eric Solary; Najet Debili; Olivier A Bernard; Hana Raslova; Albert Najman; William Vainchenker; Christine Bellanné-Chantelot; Isabelle Plo
Journal:  Nat Genet       Date:  2015-08-17       Impact factor: 38.330

Review 4.  Back to biology: new insights on inheritance in myeloproliferative disorders.

Authors:  Evan M Braunstein; Alison R Moliterno
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

Review 5.  Genomic diversity in myeloproliferative neoplasms: focus on myelofibrosis.

Authors:  Nisha R Singh
Journal:  Transl Pediatr       Date:  2015-04

Review 6.  Genetic and epigenetic alterations of myeloproliferative disorders.

Authors:  Jelena D Milosevic; Robert Kralovics
Journal:  Int J Hematol       Date:  2012-12-12       Impact factor: 2.490

Review 7.  Experimental Modeling of Myeloproliferative Neoplasms.

Authors:  Lucie Lanikova; Olga Babosova; Josef T Prchal
Journal:  Genes (Basel)       Date:  2019-10-15       Impact factor: 4.096

Review 8.  JAK2 mutants (e.g., JAK2V617F) and their importance as drug targets in myeloproliferative neoplasms.

Authors:  Karoline Gäbler; Iris Behrmann; Claude Haan
Journal:  JAKSTAT       Date:  2013-05-14

Review 9.  The JAK2 GGCC (46/1) Haplotype in Myeloproliferative Neoplasms: Causal or Random?

Authors:  Luisa Anelli; Antonella Zagaria; Giorgina Specchia; Francesco Albano
Journal:  Int J Mol Sci       Date:  2018-04-11       Impact factor: 5.923

10.  Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms.

Authors:  Roland Jäger; Ashot S Harutyunyan; Elisa Rumi; Daniela Pietra; Tiina Berg; Damla Olcaydu; Richard S Houlston; Mario Cazzola; Robert Kralovics
Journal:  Am J Hematol       Date:  2014-09-26       Impact factor: 10.047

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.